352665-38-4

Usage

Type of compound

Ester derivative

Parent compound

1,5-Imidazolidinedicarboxylic acid

Structural features

2-oxo group
tert-butyl (1,1-dimethylethyl) group
phenylmethyl group

Chirality

(5R)configuration

Potential applications

pharmaceutical properties
antimicrobial effects
anti-inflammatory effects

Fields of interest

organic synthesis
medicinal chemistry

Research status

Further research needed to fully understand its properties and potential uses.

Upstream product

• 4474-86-6 (R)-4-amino-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoic acid 
• 634614-25-8 (R)-2-oxoimidazolidine-1,5-dicarboxylic acid 1-benzyl ester 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 352665-60-2 3-[3-(4-fluoro-phenoxy)-benzyl]-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 352665-57-7 3-(4'-fluoro-biphenyl-4-ylmethyl)-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 352665-59-9 3-(4-benzyloxy-benzyl)-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 352665-58-8 3-naphthalen-2-ylmethyl-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 1426408-61-8 (R)-3-methyl-2-oxoimidazolidine-1,4-dicarboxylic acid 1-benzyl ester 4-tert-butyl ester 
• 361146-54-5 (4R)-1-[4-(4-fluorophenoxy)benzyl]-2-oxo-imidazolidine-4-carboxylic acid tert-butyl ester 
• 352665-61-3 3-[4-(naphthalen-1-yloxy)-benzyl]-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 352665-53-3 3-[4-(4-fluoro-phenoxy)-benzyl]-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 352665-62-4 3-[4-(naphthalen-2-yloxy)-benzyl]-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 
• 352665-55-5 3-(4-methoxy-benzyl)-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-tert-butyl ester 

Relevant academic research and scientific papers

A facile route to some useful homochiral alkyl imidazolidin-2-one-4(S)-carboxylates

A general, high yielding route to optically pure alkyl 1 N-alkyl and 1 N-acyl substituted imidazolidin-2-one-4(S)-carboxylates, with diverse potential uses in asymmetric synthesis, is reported.

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

The present invention provides a pyrazole compound of the following general Formula [1b] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use wherein each symbol is the same as defined in the description